U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline The Week's Pricings Three IPOs and two SPACs priced this week, and two SPACs submitted filings. No IPOs are currently scheduled for the week ahead as the year's next mega IPO potentially comes into view. Street research is expected to for one company in the week ahead, and four lock-up periods will be expiring.